Duration of Humoral Immunity to Common Viral and Vaccine Antigens
2007 · New England Journal of Medicine · 1,288 citations
https://doi.org/10.1056/nejmoa066092
M
Mark K. Slifka
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
206
Papers
15.4K
Citations
61
h-index
127
i10-index
Mark K. Slifka is an academic researcher from Oregon National Primate Research Center. The author has contributed to research in topics: T-cell and B-cell Immunology & Immune Cell Function and Interaction & Immunotherapy and Immune Responses. The author has an h-index of 61, co-authored 176 publications.
ORCID: 0000-0001-8205-6136Papers by this author
worksClinical implications of dysregulated cytokine production
2000 · Journal of Molecular Medicine · 568 citations
https://doi.org/10.1007/s001090000086
Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox
2005 · Nature Medicine · 347 citations
https://doi.org/10.1038/nm1273
Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections
2016 · Cell · 260 citations
https://doi.org/10.1016/j.cell.2016.09.049
Monkeypox virus evades antiviral CD4 <sup>+</sup> and CD8 <sup>+</sup> T cell responses by suppressing cognate T cell activation
2008 · Proceedings of the National Academy of Sciences · 161 citations
https://doi.org/10.1073/pnas.0800589105
Multivalent Smallpox DNA Vaccine Delivered by Intradermal Electroporation Drives Protective Immunity in Nonhuman Primates Against Lethal Monkeypox Challenge
2010 · The Journal of Infectious Diseases · 105 citations
https://doi.org/10.1093/infdis/jiq017
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat